HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach
| Autor: | Lebrec, H., Brennan, F.R., Haggerty, H., Herzyk, D., Kamperschroer, C., Maier, C.C., Ponce, R., Preston, B.D., Weinstock, D., Mellon, R.D. |
|---|---|
| Zdroj: | In Regulatory Toxicology and Pharmacology March 2016 75:72-80 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect